Internal Medicine Alert – June 30, 2007
June 30, 2007
View Issues
-
Tadalafil (Cialis) Improves BPH Symptoms
A randomized controlled trial of 281 men with BPH showed that once daily Tadalafil (Cialis) 20 mg improved lower urinary tract symptoms compared with placebo. -
Refining Our Risk Assessment of Colorectal Cancer in Men
A prediction tool that factors age, history of smoking, BMI, and alcohol use can determine a man's risk for colorectal cancer. -
Is Preventative PCI Better Than Optimal Medical Therapy in Patients with Stable CHD?
Although the addition of PCI to optimal medical therapy in patients with chronic stable CHD reduced the prevalence of angina, it did not reduce the long-term rates of death, nonfatal myocardial infarctions and hospitalizations for acute coronary syndromes. -
Shaking Things Up: The New Guidelines for Antibiotic Prophylaxis of Endocarditis
The new guidelines recommend antibiotic prophylaxis of infective endocarditis in a much more restricted group of patients than did previous guidelines. -
Retapamulin Ointment (Altabax™)
The FDA has approved the first of a new class of antibiotics for the topical treatment of impetigo. Retapamulin belongs to a class of agents called pleuromutilins. -
Clinical Briefs By Louis Kuritzky, MD
Unless prophylaxed, most post-stroke patients with hemiplegia develop deep venous thrombosis (DVT), and as many as 20% sustain pulmonary embolism (PE).